We are live on ! Find out more
MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Fund
S&P 500
This Quarter Est. Return
+16.24%
1 Year Est. Return
+18.92%
3 Year Est. Return
+155.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.9M
AUM Growth
-$203M
Cap. Flow
-$213M
Cap. Flow %
-1,341.55%
Top 10 Hldgs %
77.88%
Holding
26
New
3
Increased
–
Reduced
12
Closed
11

Top Buys

Rank Stock Value
1
THOR
THORATEC CORPORATION
THOR
+$945K
2
LH icon
Labcorp
LH
+$687K
3
COR icon
Cencora
COR
+$676K

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$15.9M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$15.6M
3
DXCM icon
DexCom
DXCM
+$15.2M
4
AMGN icon
Amgen
AMGN
+$12.8M
5
UHS icon
Universal Health Services
UHS
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 78.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UAM
26
DELISTED
Universal American Corp
UAM
– –
-1,128,043
Closed -$10.5M
1
2

Similar funds

IC
IKOS CIF Limassol, Cyprus $16.7M AUM 0.4% 1-Year Est. Return
PA
Para Advisors New York $17.5M AUM 3.99% 1-Year Est. Return
GMIM
General Motors Investment Management New York $20.3M AUM 55.51% 1-Year Est. Return
JHWCP
J.H. Whitney Capital Partners New Canaan, Connecticut $11.5M AUM 86.36% 1-Year Est. Return
SMPIAI
Spark Management Partners III (AIV I) Boston, Massachusetts $10.1M AUM 12.29% 1-Year Est. Return
NCMG
NCM Capital Management Group Durham, North Carolina $8.24M AUM 11.99% 1-Year Est. Return
CAD
Craig A. Drill $24.4M AUM 13.42% 1-Year Est. Return
GPI
Georgian Partners I Toronto, Ontario, Canada $25.3M AUM 21.88% 1-Year Est. Return

March Altus Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, March Altus Capital Management held 26 positions worth $15.9M, down 93% from $219M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

March Altus Capital Management withdrew a net $213M in Q1 2015, closing 11 positions and reducing 12 holdings. Its most notable exit was Amgen, an estimated $12.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 82% a quarter earlier.

Against the trend, March Altus Capital Management opened a new position in THORATEC CORPORATION worth $1.04M.

  • March Altus Capital Management's largest Q1 2015 buy was THORATEC CORPORATION: 24,765 shares worth $1.04M.
  • March Altus Capital Management's biggest Q1 2015 reduction was United Therapeutics, cutting an estimated $15.9M.
  • March Altus Capital Management fully exited Amgen in Q1 2015, selling an estimated $12.8M.
  • March Altus Capital Management's ten largest holdings make up 78% of its $15.9M portfolio in Q1 2015.
  • March Altus Capital Management opened 3 new positions and closed 11 in Q1 2015.
  • March Altus Capital Management's portfolio value fell 93% quarter-over-quarter to $15.9M.

Based on March Altus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.